Delving into the Latest Updates on Shenzhen Yingsheng Biomedical Co., Ltd. with Synapse

Overview

Tags

Neoplasms

Digestive System Disorders

Other Diseases

Biological products

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

No Data

Disease Domain	Count

Neoplasms	1

Top 5 Drug Type	Count

Biological products	1

主要目的： 1.评估mp105治疗晚期非小细胞肺癌、结直肠癌和食管鳞癌受试者的安全性和耐受性 2.确定mp105治疗晚期非小细胞肺癌、结直肠癌和食管鳞癌受试者的最大耐受剂量（MTD）、扩展推荐剂量（RDE）和/或II期推荐剂量（RP2D）次要目的： 1.评估mp105治疗晚期非小细胞肺癌、结直肠癌和食管鳞癌受试者的药代动力学（PK）特征 2.评估mp105治疗晚期非小细胞肺癌、结直肠癌和食管鳞癌受试者的抗肿瘤活性探索性目的： 1.探索mp105治疗晚期非小细胞肺癌、结直肠癌和食管鳞癌受试者的生物标志物特征 2.初步评估mp105的免疫原性

[Translation]

Primary Objectives: 1. Evaluate the safety and tolerability of mp105 in patients with advanced non-small cell lung cancer, colorectal cancer, and esophageal squamous cell carcinoma 2. Determine the maximum tolerated dose (MTD), recommended dose for expansion (RDE), and/or recommended phase II dose (RP2D) of mp105 in patients with advanced non-small cell lung cancer, colorectal cancer, and esophageal squamous cell carcinoma Secondary Objectives: 1. Evaluate the pharmacokinetic (PK) characteristics of mp105 in patients with advanced non-small cell lung cancer, colorectal cancer, and esophageal squamous cell carcinoma 2. Evaluate the anti-tumor activity of mp105 in patients with advanced non-small cell lung cancer, colorectal cancer, and esophageal squamous cell carcinoma Exploratory Objectives: 1. Explore the biomarker profile of mp105 in patients with advanced non-small cell lung cancer, colorectal cancer, and esophageal squamous cell carcinoma 2. Preliminary assessment of the immunogenicity of mp105

Start Date-

Sponsor / Collaborator

Shenzhen Yingsheng Biomedical Co., Ltd.

100 Clinical Results associated with Shenzhen Yingsheng Biomedical Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Shenzhen Yingsheng Biomedical Co., Ltd.

Login to view more data

100 Deals associated with Shenzhen Yingsheng Biomedical Co., Ltd.

Login to view more data

100 Translational Medicine associated with Shenzhen Yingsheng Biomedical Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 04 Mar 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 1

1

Login to view more data